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ABSTRACT 
Purpose: To evaluate indocyanine green angiography (ICGA) for the identification and 
characterization of afferent (feeding) and efferent (draining) vessels in patients with ocular 
surface neoplasia.  
Materials and Methods: Consecutive patients with biopsy-proven benign, pre-invasive or 
invasive ocular surface tumors of the bulbar conjunctiva were included. Patients underwent 
anterior segment optical coherence tomography, ICGA, and colour photography for the 
evaluation of the thickness, location, number and diameter of afferent and efferent vessels of 
the lesions.  
Results: Twenty-two eyes of 22 patients with papillomas (n=4), intra-epithelial neoplasia 
lesion (n=2) in situ or invasive carcinomas (n=6), nevus (n=5), conjunctival melanocytic intra-
epithelial neoplasia lesion (n=1), and in situ or invasive melanomas (n=4) were investigated. 
Afferent (feeder) vessels were identified in all lesions. There were fewer afferent (3.1 ± 1.6) 
than efferent (7.5 ± 3.5) vessels per lesion (p<0.001) and the mean diameter was smaller for 
afferent (101± 62 μm, 28-281) than efferent vessels (137 ± 51 μm,  31-652; p=0.017). The 
number of afferent and efferent vessels was associated with the thickness of the lesion 
(p=0.037, p<0.01). Lesion filling times differed between benign and invasive or pre-invasive 
lesions (p=0.018).  
Conclusions: ICGA is a useful adjunctive in vivo imaging method for the assessment of the 
vasculature in patients with suspected ocular surface neoplasia. 
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INTRODUCTION 
Characterising the vasculature of neoplastic lesions is important in assessing tumour 
development, growth and response to treatment.(1) Pathological angiogenesis is a particular 
hallmark of solid neoplasia. Sufficient supply of oxygen and nutrients is critical for neoplastic 
cell proliferation and tumour survival.(2) While very small, early stage tumours may obtain 
their oxygen and nutrients by means of diffusion from surrounding tissue vessels, larger 
tumors that grow beyond a size of 2 mm3 can no longer be sustained by diffusion and require 
an internal blood supply.(3) The vasculature of tumours, however, is complex and vessel 
networks in tumours have unique features that differ fundamentally from those seen in 
normal vasculature. (4,5) These typically consist of a disorganized labyrinth of vessels which 
lack the conventional hierarchy of arterioles, capillaries and venules seen in normal vascular 
networks.(4) Tumour vessels are often tortuos with variable diameters, abnormal bulges and 
blind ends; sometimes accompanined by arteriolar-venous shunts and plasma channels 
lacking red blood cells.(6) The vessels are poorly invested with smooth muscle cells and may 
have a discontinuous endothelial cell lining with an abnormal basement membrane, resulting 
in increased vessel permeability.(7)  
Several imaging methods such as magnetic resonance imaging (MR), computed tomography 
(CT), positron emission tomography, Doppler ultrasonography, and spectroscopy are used to 
evaluate vascular networks.(8) In the field of ophthalmology, fluorescein and indocyanine 
green angiography (FA and ICGA) are a very well established and widely used imaging 
method for the diagnosis and management of a variety of chorioretinal vascular 
diseases.(9,10) Anterior segment angiography can also be used to investigate the ocular 
surface vasculature and has gained growing popularity for the clinical assessment of a 
variety of corneal and and extracorneal ocular surface diseases in recent years.(11,12)  The 
better delineation of vessels compared to biomicrosopic assessment and the capability to 
identify the afferent and efferent vessels makes this imaging technique an invaluable tool for 
investigating morphological vessel characteristics and blood flow dynamics in vascularized 
lesions. (13-15) ICGA and FA in conjunction with objective computer-assisted image analysis 
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has been demonstrated to provide a reliable method for quantifying vessel change in corneal 
angiogenesis by measuring vessel parameters such as diameter, length, branch pattern and 
tortuosity.(13) Leakage of fluorescein using FA may reflect vessel maturity and offer the 
potential to functionally stage angiogenesis.(16) 
In contrast to choroidal and retinal lesions, vessel characteristics and haemodynamics in 
ocular surface tumours are still poorly understood and the clinical and prognostic role of 
tumour-feeding (afferent) and draining (efferent) vessels remains unkown. In this study we 
evaluated the use of indocyanine green angiography to identify and assess afferent and 
efferent vessels in patients with benign and malignant neoplastic lesions of the ocular 
surface. 
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MATERIALS AND METHODS 
Patients referred to the Liverpool Ocular Oncology Service between March and October 
2016 with clinically evident pigmented and non-pigmented tumours of the limbal and extra-
limbal bulbar conjunctiva were prospectively recruited. All participants had a detailed slit-
lamp biomicroscopy and underwent subsequent anterior segment imaging including colour 
photography, AS-OCT and indocyanine green angiography during the same visit. Patient 
demographics (age, gender, ethnicity) and clinical tumour characteristics (size, thickness, 
location, limbal involvement, pigmentation) were collected using a standardised data 
collection sheet. Tumours with diffuse margins or indiscernible vessels and tumours with 
non-bulbar conjunctival location were excluded. All patients underwent excisional or 
incisional biopsy for histopathology. All specimens were assessed by an experienced 
pathologist at the pathology department of our institution. For pre-invasive melanocytic 
neoplasia, the term conjunctival melanocytic intra-epithelial neoplasia (C-MIN) was used 
(also referred to as PAM with atypia), and the severity of dysplasia was graded using the 
histopathological classification system (score 1-10) of Damato and Coupland.(17) None of 
the patients had had previous treatment for their ocular surface tumours. Informed consent 
was obtained from all subjects and the study was appoved by the Institutional Review Board 
and adhered to the Tenets of the Declaration of Helsinki.  
 
Colour images 
Colour images were recorded using a slit lamp mounted digital system (SL-D Digital Slit 
Lamp; Topcon, Tokyo, Japan) as per our existing protocol for standardised colour images: 
The entire ocular surface was imaged in all 9 positions of gaze using a 10x to 25x 
magnification and illumination from a 45 degree angled beam on slit lamp biomicroscopy with 
a diffuser filter and a variable flash intensity. A total of 18 color images (9 images per eye) 
were obtained for each patient. 
 
Anterior-segment optical coherence tomography 
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Anterior segment OCT was performed with an OCT lens in conjunction with the HRA2 
Scanning Laser Ophthalmoscope (Heidelberg Engineering, Heidelberg, Germany) for 
thickness measurements of tumours. Cross sectional scans at an angle of 0 and 90 degrees 
were obtained for every lesion and the measurments were taken at the thickest tumour 
location.   
 
Indocyanine Green Angiography 
An HRA2 Scanning Laser Ophthalmoscope (Heidelberg Engineering, Heidelberg, Germany) 
with a 20° imaging lens and a focus setting of +32.00D was used for ICGA as previously 
described.(13,14,16) After intravenous injection of 5ml of 5mg/ml indocyanine green dye 
(Pulsion Medical Systems, Munich, Germany) into a peripheral arm vein, videography was 
undertaken for 30 to 60 seconds concentrating on the region of interest (ROI), commencing 
when the dye fluoresced within the eyelids, usually approximately 10 seconds after the 
injection (depending on age of the patient and the location of the ROI).(16) Following 
videography, single-frame ICGA photographs of the ROI including the tumour and 
surrounding blood vessel fluorescence were captured at a 32 to 34x magnification every 3 to 
5 seconds for 3 minutes in high-resolution mode incorporating automatic real-time (ART) 
software. 
 
Image analysis 
ICGA video frames were used to identify the afferent (feeding) and efferent (draining) vessels 
of each lesion. Afferent vessels were defined as those vessels in which the dye first 
appeared with anterograde filling towards the tumour. Efferent vessels were defined as 
vessels filling in a retrograde fashion away from the tumor during or with a latency to 
intralesional vessel filling. Lesion filling time was defined as the time interval (in seconds) 
between first dye appearance in afferent and first dye appearance in efferent tumour vessels. 
The ICGA images were graded using a subjective quality score of 0 to 4 as previously 
described (0, no vessel discernible; 1, poor vessel delineation; 2, good vessel delineation; 3, 
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very good vessel delineation; 4, excellent vessel delineation).(13) The two best-quality 
frames demonstrating, first filling of afferent vessels and then complete filling of efferent 
vessels were independently assessed by two observers (M.B. and V.R.). The two best-
quality frames with complete afferent and efferent vessel filling of the ROI were then selected 
by the same two observers for calculation of vessel diameters. This was performed using an 
in-house automated program written in numerical computing language (Matlab R14; The 
Mathworks Inc., Natick, MA) as described and validated elsewhere.(13) Briefly, the software 
can detect vessels and extract quantitative information of the detected vasculature by 
performing a series of image processing tasks mainly including image enhancement, 
enhancement of vessel structures and conversion to binary images. The pixel resolution 
(mm/pixel) of the angiographic images, defined as the ratio between the diameter of the 
cornea (12 mm) and the image diameter of the tumour (or two set landmarks within the 
lesion) in pixels, was estimated by identifying the limbus to limbus diameter manually and 
calculation of the pixels number within these landmarks. The vessel diameters were 
measured within a distance of 0.5 to 1 mm from the tumour margin. The orientation of tumour 
vessels was categorized as the ‘“same’, if the entry and exit points of afferent and efferent 
vessels at the tumour margin were located less then 90 degrees apart, and as ’opposite’, if 
these were located more than 90 degrees apart. 
 
Statistical analysis 
Data were expressed as means ± SD. The Shapiro-Wilk test was used to test for non-normal 
distribution of the data. The Mann-Whitney U test was used to compare vessel number, 
diameter and lesion filling times. P values of less than 0.05 were considered statistically 
significant. Levels of agreement were tested using Fleiss' Kappa Statistic (k). Interpretation 
of levels of agreement were be based on that described for two (binary) categories for each 
patient. A value of <0.2, k was considered slight, 0.2< k < 0.4 fair; 0.4 < k < 0.6 moderate, 
0.6 < k < 0.8 substantial and k > 0.8 as almost perfect. Statistical analyses were performed 
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with the Statistical Package for the Social Sciences Software (IBM SPSS Version 22.0 for 
MAC; SPSS Inc., Chicago, IL). 
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RESULTS 
Twenty-two eyes of 22 patients (median, 68 years; range, 23-88 years; female-to-male ratio, 
6:16) with ocular surface neoplasia of the bulbar conjunctiva were included. The 
demographic patient data and clinical tumour characteristics are included in Table 1. The 
majority of patients were caucasians (n=16). The examined tumours included 12 squamous  
lesions (4 papillomas, 2 intra-epithelial neoplasia lesions (CIN 2), 5 in situ carcinomas (CIN 
3), 1 invasive carcinoma, SCC), and 10 melanocytic lesions (5 naevi, 1 melanocytic intra-
epithelial neoplasia lesion (C-MIN score 3), 1 melanoma in situ, and 3 invasive melanomas). 
The temporal bulbar conjunctiva was the most common site of involvement (n=11) and the 
majority of lesions involved the limbus (n=14) with or without corneal extension. Eleven 
lesions presented with intrinsic pigmentation. The mean largest basal diameter and 
maximum tumour thickness measured 8.3 ± 3.5 mm (range, 3-16) and 724 ± 299 μm (range, 
346-1217), respectively. All eyes underwent complete excision (n=20) or incisional biopsy 
(n=2) and histopathological diagnosis was confirmed in all cases (Table 1).  
Inter-observer agreement for grading the quality of image assessment and was substantial 
for the selected ICGA frames (k=0.72; p<0.01) and excellent for afferent and efferent vessel 
identification (k=0.88; p<0.01). The vessel parameters are summarized in Table 2. A mean of 
3.1 ± 1.6 (range, 1-7) afferent and 7.5 ± 3.5 (range, 2-14) efferent vessels were found per 
lesion (p<0.001). The ratio of the number of afferent to efferent vessels was 0.49 ± 0.28 
(range, 0.17-1.25). Afferent and efferent vessel diameters ranged from 28 to 281 μm (mean, 
101; SD ± 51) and 31 to 652 μm (mean, 136; SD, ± 62), respectively (p=0.2) with a ratio of 
0.80 ± 0.35 (range, 0.7-1.6). 
Afferent and efferent vessel number and diameter varied among the different patient 
subgroups (Table 3, supplementary data), but did not differ significantly between squamous 
and melanocytic lesions, or between benign and pre-invasive or invasive lesions. There were 
significant associations between the number of afferent (R2=0.59, p=0.037), and efferent 
(p<0.01) vessels, vessel diameter (R2=0.35, P=0.05) and tumour thickness, but not with the 
size (largest basal diameter) of the lesion. Intralesional filling times were significantly longer 
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in benign (3.19 ± 2.20 sec) than pre-invasive (2.49 ± 1.10 sec) or invasive lesions (1.95 ± 
0.81 sec) (p=0.018), and were also dependent on the location of vessel entry and exit points 
at the tumour margins (p=0.001).  
In two patients with papillomas, the conformation of the afferent vessels was more coiled 
relative to the accompanying efferent vessels, as demonstrated in Figure 1A-C. In some 
neoplasms, afferent vessels accompanied efferent vessels, biomicroscopically presenting as 
finer vessels aligning the efferent vessels in a parallel fashion (Figures 2A-C). In other 
lesions, afferent vessels were not located in close proximity to efferent vessels (Figures 3A-
C). The discord between afferent and efferent vessel diameters was most noticeable in 
papillomas, as these lesions presented with relatively small afferent and larger-diameter 
efferent vessels compared to other lesions. Of note, none of the afferent vessels in the 
examined lesions showed the increased tortuosity as commonly seen in efferent vessels. 
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DISCUSSION 
The architecture and haemodynamics of vascular networks has been investigated in various 
extraocular tumours.(4,5,18) To the best of our knowledge, this is the first study to report the 
use indocyanine green angiography (ICGA) for identification and evaluation of afferent and 
efferent vessel parameters in various ocular surface tumors including benign, pre-invasive 
and invasive lesions. The use of ICGA for the evaluation and treatment of corneal 
neovascularization has been well documented. (13,14,16) ICGA has been shown to provide 
excellent vessel delineation and to differentiate afferent and efferent vessels in neovascular 
corneal networks and in allergic eye disease.(13,14,16,19,20) In this study, the systematic 
analysis of videoangiography frames enabled us to evaluate the dye appearance dynamics 
of vascular networks in each lesion. This allowed for consistent identification of afferent 
vessels, possibly representing tumour-feeding arteries, and their efferent counterparts, 
presumably representing draining veins. Using the angiographic images it was possible to 
differentiate afferent and efferent vessels on biomicroscopy and in colour images. Similar to 
the good imaging of corneal neovascularisation in the presence of scars or exudate, imaging 
of the tumour vasulature with ICGA was obtained regardless of the thickness of the lesion. 
This is important as the vasculature of thicker lesions is very difficult to discern with colour 
photography. Unlike fluorescein, indocyanine green does not show vessel leackage in early 
filling phases, and as such is more suitable for fluorescence angiographic vessel delineation 
in ocular surface lesions. 
The term ’feeder vessel’ is widely used to describe clinical features of ocular surface tumours 
and usually refers to prominent tumor vessels seen on biomicroscopy. None of the tumour 
vessels with prominent appearance on colour images represented afferent i.e true feeder 
vessels in our case series. Our findings would suggest that this terminology may represent a 
misnomer in a considerable proportion of cases, as it may be impossible to accurately 
identify the true afferent and efferent tumour vessels based on biomicrosopy or colour 
images alone. We would therefore suggest that the terms feeder and drainer vessels only be 
used if confirmed with angiography or other imaging modes which provide 'direction of flow' 
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information. The presence of feeder vessels has been considered to represent a possible 
risk factor for malignancy in different studies.(21,22) When interepreting these data it has to 
be considered that the presumed feeder vessels in these studies were based solely on 
biomicroscopic findings and may have included afferent and efferent vessels or perhaps 
efferent vessels only.  
The identification of afferent tumour vessels using fluorescence angiography may also have 
potential clinical implications for the pre- and peri-operative management of ocular surface 
neoplasia. Interestingely, we observed a significant association of lesional vessel filling times 
and the tumour dignity, with longer filling times in benign than in pre-invasive or invasive 
lesions. We hypothesize that these findings may indirectly reflect haemodynamic changes 
caused by the structural vascular heterogeneity in tumours, which may vary with the severity 
of disease i.e grade of dysplasia. Increased structural heterogeneity of vascular networks is a 
well-known feature of neoplastic lesions(5) Vascular networks of tumours contain tortuous 
vessels, shunts, vascular loops, widely variable intervascular distances, and large avascular 
areas(1,4,18), and regions of stagnant or intermittent blood flow within these networks have 
been observed.(23,24) Functional shunts within vascular networks of induced squamous 
carcinoma in a mouse model have been demonstrated using intravital microscopy(5). 
Increased (functional) shunting may also explain the different filling times observed for the 
tumours in our cohort, and as such, may have the potential to be used as diagnostic 
biomarkers for the severity of disease in ocular surface neoplasia. 
Angiographically guided identification and selective fine needle diatheremy (FND) to the 
afferent (feeder) vessels has been shown to minimise the amount of diathermy needed to be 
effective in treating corneal neovascularisation.(14) Preoperative selective occlusion of 
afferent vessels with FND(14,25) may therefore reduce intraoperative bleeding during tumour 
excisions and reduce the risk of potential tumour seeding in invasive melanomas. Shutting 
down the blood supply may in addition cause necrosis-induced tumour involution, thereby 
facilitating the surgical management of extensive mass lesions and contributing to the 
eradication of the tumour.  
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There are several limitations to this study. The case numbers were small with lesion 
heterogeneity (diagnosis, size and duration), and in particular there was selection bias; only 
inlcuding nodular ocular surface lesions with well-defined tumour margins. Patients with very 
extensive or diffuse lesions, and lesions involving the fornix or palpebral conjunctiva, were 
not investigated as such lesions are difficult to approach angiographically. Furthermore, only 
a small proportion of patients presenting with OSN were willing to undergo additional 
examinations including fluorescence angiography for study purposes. Due to the small 
number of patients with different types of neoplasia we may not have been able to detect 
differences in afferent and efferent vessel number and diameter between lesion type. 
Despite these limitations we found ICGA to be a useful imaging method for the assessment 
of the vasculature in patients with suspected ocular surface neoplasia arising from the bulbar 
conjunctiva. Angiography enables accurate identification and localisation of afferent and 
efferent vessels and their respective characteristics. As in lesions elsewhere in the body, 
these vascular parameters may be of help in the assessment and management of patients 
with benign and malignant neoplastic lesions of the ocular surface. 
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Figure 1. A, Slit-lamp photograph of a 97-year-old male patient showing a conjunctival 
papilloma, with afferent (black arrows) and efferent (black points) tumor vessels. B, 
Angiographic image of same eye (ICGA, 0:21:64 sec) showing afferent vessels (white 
arrows). C, Angiographic image of same eye showing (ICGA, 0:32:86 sec) efferent 
vessels (white points). 
 
Figure 2. A, Slit-lamp photograph of a 29-year-old male patient showing conjunctival invasive 
melanoma, with afferent (black arrows) and efferent (black points) tumor vessels. B, 
Angiographic image of same eye (ICGA, 0:12:37 sec) showing afferent vessels (white 
arrows). C, Angiographic image of same eye showing (ICGA, 0:29:35 sec) efferent 
“drainier” vessels (white points). 
 
Figure 3. A, Slit-lamp photograph of a 55-year-old male patient showing conjunctival and 
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corneal intraepithelial neoplasia (CIN 2), with afferent (black arrows) and efferent 
(black points) tumor vessels. B, Angiographic image of same eye (ICGA, 0:10:28 sec) 
showing afferent vessels (white arrows). C, Angiographic image of same eye showing 
(ICGA, 0:17:86 sec) efferent vessels (white points). 
Table 1. Patient Demographics and Clinical Tumour Characteristics 
    Patient No. (Gender, 
Laterality) 
Age 
(Years) Ethnicity 
Histopathological 
Diagnosis* 
Location (Bulbar 
Quadrant) 
Limbal 
Involvement 
Intrinsic 
Pigmentation 
Largest Tumour 
Diameter [mm] 
Tumour 
Thickness [μm] 
1 (M, OD) 79 Caucasian Papilloma Temporal, inferior yes no 16.0 980 
2 (M, OD) 59 Caucasian Papilloma Inferior no no 5.1 457 
3 (F, OS) 58 Caucasian Papilloma Inferior no no 10.6 1173 
4 (M, OS) 80 Caucasian Papilloma Temporal yes no 6.7 556 
5 (M, OS) 55 African CIN 2 Temporal, inferior yes yes 11.5 549 
6 (M, OD) 72 Caucasian CIN 2 Nasal yes no 5.5 1107 
7 (M, OS) 64 Caucasian CIN 3 (CIS) Temporal no no 5.5 673 
8 (M, OD) 82 Indian CIN 3 (CIS) Temporal yes no 8.5 389 
9 (F, OS) 86 Caucasian CIN 3 (CIS) Nasal, superior yes no 10.0 1217 
10 (M, OD) 81 Caucasian CIN 3 (CIS) Nasal yes no 8.0 517 
11 (M, OD) 82 Caucasian CIN 3 (CIS) Inferior, nasal, 
superior 
yes no 11.5 417 
12 (M, OS) 75 Caucasian SCC Nasal yes no 5.8 1160 
13 (F, OS) 77 Caucasian Naevus Nasal no yes 3.7 407 
14 (F, OS) 33 Caucasian Naevus Nasal no yes 11.0 1042 
15 (F, OD) 31 Caucasian Naevus Superior, temporal yes yes 3.0 448 
16 (M, OS) 37 Middle-Eastern Naevus Temporal yes yes 4.9 579 
17 (M, OD) 23 Middle-Eastern Naevus Temporal no yes 9.4 585 
18 (F, OD) 63 Hispanic C-MIN (Score 3)† Temporal yes yes 4.6 346 
19 (M, OS) 75 Caucasian Melanoma in situ Inferior, nasal yes yes 15.1 588 
20 (M, OS) 88 Caucasian Melanoma Temporal, inferior yes yes 10.4 731 
21 (M, OD) 29 Middle-Eastern Melanoma Temporal no yes 6.5 923 
22 (M, OD) 56 Caucasian Melanoma Nasal no yes 10.0 1090 
         Mean 63.0 
     
8.3 724 
± SD 20.5 
     
3.5 299 
Min-Max 23-88 
     
3.0-16.0 346-1217 
         F=female; M=male; OD=right eye; OS=left eye; CIN=conjunctival/corneal intraepithelial neoplasia; C-MIN=conjunctival/corneal melanocytic intraepithelial 
neoplasia; CIS=squamous cell carcinoma in situ; SCC=invasive squamous cell carcinoma. 
*All patients unterwent excisional (n=20) or incisional biopsy (n=2). 
    †Classification of C-MIN based on scoring systems (0-10) by Damato and Coupland.           
 
Table 2.  Angiographic Parameters of Afferent and Efferent Tumour Vessels 
     Vessel No.   Mean Vessel Diameters (± SD, min-max) [μm] Intralesional vessel 
filling [sec]† Patient No. Afferent Efferent Ratio*   Afferent Efferent Ratio* 
1 3 12 0.25 
 
98 (± 24, 72-117) 212 (± 156, 110-644) 0.46 0.84 
2 2 2 1.00 
 
95 (± 0, 0)  164 (± 43, 133-195) 0.58 8.41 
3 4 11 0.36 
 
174 (± 76, 101-281) 208 (± 125, 87-520) 0.84 2.95 
4 2 8 0.25 
 
158 (± 96, 90-226) 179 (± 63, 83-263) 0.88 3.81 
5 1 3 0.33 
 
121 (± 0, 0)  109 (± 18, 95-129) 1.11 0.97 
6 3 7 0.43 
 
46 (± 13, 32-58) 65 ± (17, 51-99) 0.71 1.47 
7 3 9 0.33 
 
115 (± 48, 70-166) 135 (± 36, 87-202) 0.85 3.67 
8 2 2 1.00 
 
241( ± 22, 226-256) 190 (± 4, 188-193) 1.27 2.32 
9 4 10 0.40 
 
60 (± 8, 51-70) 88 (± 37, 47-167) 0.68 2.93 
10 1 5 0.20 
 
64 (± 0, 0)  82 (± 14, 70-104) 0.78 2.2 
11 3 14 0.21 
 
38 (± 15, 28-49) 144 (± 34, 102-192) 0.26 1.37 
12 3 7 0.43 
 
42 (± 6, 36-48) 115 (± 69, 62-257) 0.37 1.06 
13 3 6 0.50 
 
55 (± 16, 43-73) 102 (± 23, 80-144) 0.54 3.42 
14 3 6 0.50 
 
40 (± 12, 30-54) 130 (± 56, 89-222) 0.31 2.54 
15 3 7 0.43 
 
69 (± 26, 44-95) 69 (± 17, 52-90) 1.00 1.27 
16 5 4 1.25 
 
107 (± 52, 62-192) 85 (± 13, 75-103) 1.26 3.5 
17 3 4 0.75 
 
108 (± 27, 91-140) 136 (± 24, 101-157) 0.79 2 
18 3 7 0.43 
 
94 (± 26, 69-121) 81 (± 39, 41-138) 1.16 3.5 
19 7 10 0.70 
 
103 (± 20, 74-125) 101 (± 16, 82-122) 1.02 4 
20 2 12 0.17 
 
164 (± 71, 113-214) 103 (± 30, 31-180) 1.59 2.5 
21 7 13 0.54 
 
146 (± 45, 86-208) 178 (± 98, 72-372) 0.82 1.48 
22 2 6 0.33 
 
91 (± 16, 79-102) 332 (± 197, 159-652) 0.27 2.75 
         Mean 3.1 7.5 0.49 
 
101.32 136.73 0.80 2.68 
± SD 1.6 3.5 0.28 
 
51.38 62.41 0.35 1.62 
Min-Max 1-7 2-14 0.17-1.25 
 
38-241 65-332 0.26-1.59 0.84-8.41 
         *Afferent to efferent vessels.  
      †Defined as time period between first dye appearance in afferent and first dye appearance in efferent vessels (in seconds).   
 
Supplementary data 
Table 3.  Subgroup Comparison of Afferent and Efferent Tumour Vessel Parameters  
      Mean No. of Vessels (± SD, Min-Max)     Mean Vessel Diameters (± SD, Min-Max) [μm] 
Subgroups (n) Afferent Efferent Ratio*   Afferent Efferent Ratio* 
Cell type 
       Melanocytic (10) 3.8 (± 1.9, 2-7) 7.5 (± 3.1, 4-13) 0.56 (± 0.29, 0.17-1.25) 
 
98 (± 38, 40-164) 132 (± 77, 69-332) 0.88 (± 0.41, 0.27-1.59) 
Squamous (12) 2.6 (± 1.0, 1-4) 7.5 (± 4.0, 2-14) 0.43 (± 0.27, 0.20-1.00) 
 
104 (± 62, 38-241) 141 (± 50, 65-212)  0.73 (± 0.29, 0.26-1.27) 
P-value 0.1 0.8 0.09 
 
0.9 0.2 0.3 
        Classification 
       Benign (9) 3.1 (± 0.9, 2-5) 6.7 (± 3.3, 2-12) 0.58 (± 0.34, 0.25-1.25) 
 
100 (± 44, 40-174) 143 (± 52, 69-212) 0.74 (± 0.30, 0.31-1.26) 
Pre-invasive or invasive (13) 3.2 (± 1.9, 1-7) 8.1 (± 3.7, 2-14) 0.42 (± 0.22,0.17-1.00 ) 
 
102 (± 58, 38-241) 133 (± 71, 65-332) 0.84 (± 0.39, 0.26-1.59) 
P-value 0.5 0.3 0.1 
 
0.8 0.4 0.6 
        Location 
       Limbal (14) 3 (± 1.6, 1-7) 7.8 (± 3.6, 2-14) 0.46 (± 0.32, 0.17-1.25) 
 
100 (± 57, 38-241) 116 (± 47, 65-212) 0.89 (± 0.38, 0.26-1.59) 
Extra-limbal (8) 3.4 (± 1.6, 2-7) 7.1 (± 3.6, 2-13) 0.53 (± 0.23, 0.33-1.00) 
 
103 (± 44, 40-174) 173 (± 72, 102-332) 0.63 (± 0.24, 0.27-0.85) 
P-value 0.5 0.5 0.2 
 
0.7 0.04 0.1 
        Vessel orientation 
       Same (14) 3.5 (± 1.7, 1-7) 7.9 (± 4.0, 2-14) 0.53 (± 0.30, 0.17-1.25) 
 
106 (± 60, 38-241) 134 (± 46, 65-212) 0.81 (± 0.40, 0.26-1.59) 
Opposite (8) 2.5 (± 0.9, 1-4) 6.8 (± 2.5, 2-10) 0.42 (± 0.25, 0.20-1.00) 
 
93 (± 32, 60-158) 141 (± 88, 69-332) 0.78 (± 0.27, 0.27-1.16) 
P-value 0.1 0.5 0.2 
 
0.6 0.5 0.9 
       
 
*Afferent to efferent vessels 
       †Location of entry and exit points of afferent and efferent vessels at tumour margin (same=within 90 degrees; opposite=more than 90 degrees apart).  
 
